Results 191 to 200 of about 328,224 (217)

Organ-System Predictors of Immune-Related Adverse Events and Their Prognostic Impact in Immune Checkpoint Inhibitors-Treated Cancer Patients: A MENA Retrospective Cohort. [PDF]

Cancers (Basel)
Awada A, Tarhini A, Hammoud A, Kassem M, Rizkallah J, Al Hajjar M, Dakik A, Romanos M, Faraj S, Awada D, Soueid L, Wehbe R, Kalout K, Charbel N, Kreidieh F.   +14 more
europepmc   +1 more source

Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors: A Scoping Review. [PDF]

Pharmaceuticals (Basel)
Tacchi C, Convertino I, Bocci G.
europepmc   +1 more source

Dermatologic immune-related adverse events associated with immune checkpoint inhibitors: A prospective real-world observational study in Switzerland. [PDF]

JAAD Int
Trösch A, Zahn CA, Cazzaniga S, Özdemir BC, Feldmeyer L, Benzaquen M.   +5 more
europepmc   +1 more source

Immune checkpoint inhibitor-related intestinal pseudo-obstruction and multisystem immune-related adverse events in a post-gastrectomy patient: a case report and literature review. [PDF]

Front Oncol
Liu Z, Wang C, Shen Y, Shi Y, Duan J, Dong H, Xu Y, Zheng Y, Cui H.   +8 more
europepmc   +1 more source

Genomic co-alterations and immune-related adverse events shape outcomes of thymic malignancies treated with immune checkpoint inhibitors. [PDF]

NPJ Precis Oncol
Tan HN, Le H, Frej KBH, Kang L, Champiat S, Meric-Bernstam F, Fossella F, Naing A, Sharon E, Altan M, Dumbrava EE.   +10 more
europepmc   +1 more source

Metachronous severe multisystem immune-related adverse events during tremelimumab plus durvalumab therapy for hepatocellular carcinoma: a clinicopathological autopsy case report. [PDF]

Front Oncol
Nosaka T, Yamashita J, Akazawa Y, Tanaka T, Takahashi K, Naito T, Ohtani M, Kimura Y, Imamura Y, Tada H, Kobayashi M, Nakamoto Y.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Novel classification for adverse events in GI endoscopy: the AGREE classification

Gastrointestinal Endoscopy, 2022
Siwan Thomas-Gibson, Paul Fockens, Evelien Dekker   +2 more
exaly  

Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Clinical Trials, 2021
Monica Bertagnolli, Thomas M Atkinson, Deborah Bruner   +2 more
exaly  

Adverse Events After Total Hip Arthroplasty are not Sufficiently Characterized by 30-Day Follow-Up: A Database Study

Journal of Arthroplasty, 2023
Jonathan N Grauer, Lee Rubin, Alex Kammien   +2 more
exaly